APA (7th ed.) Citation

Zhou, J., Lai, J., Cheng, Y., & Qu, W. (2022). NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway. Evidence-based complementary and alternative medicine, 2022, 1-9. https://doi.org/10.1155/2022/1890823

Chicago Style (17th ed.) Citation

Zhou, Jiancheng, Jiawei Lai, Yongyi Cheng, and Weixing Qu. "NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway." Evidence-based Complementary and Alternative Medicine 2022 (2022): 1-9. https://doi.org/10.1155/2022/1890823.

MLA (9th ed.) Citation

Zhou, Jiancheng, et al. "NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway." Evidence-based Complementary and Alternative Medicine, vol. 2022, 2022, pp. 1-9, https://doi.org/10.1155/2022/1890823.